18.6 Acknowledgments
The authors are grateful to Dr. Holger Berk (Caltech, USA) for valuable comments
during the preparation of this chapter.
18.7 References
Adas, F., Salaun, J. P., Berthou, F., Picart, D., Simon, B., Amet, Y. (1999), Requirement forxand (x-1)-
hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11,J. Lipid Res. 40 , 1990–1997.
Bambal, R. B., Hanzlik, R. P. (1996a), Active site structure and substrate specificity of cytochrome P450
4A1: steric control of ligand approach perpendicular to heme plane,Biochem. Biophys. Res. Commun.
219 , 445–449.
Bambal, R. B., Hanzlik, R. P. (1996b), Effects of steric bulk and conformational rigidity on fatty acidx-
hydroxylation by a cytochrome P450 4A1 fusion protein,Arch. Biochem. Biophys. 334 , 59–66.
Barnes, H. J., Arlotto, M. P., Waterman, M. R. (1991), Expression and enzymatic activity of recombinant
cytochrome P450 17a-hydroxylase inEscherichia coli.,Proc. Natl. Acad. Sci. USA, 88, 5597–5601.
Barnes, H. J. (1996), Maximizing expression of eukaryotic cytochrome P450s inEscherichia coli,Meth-
ods Enzymol. 272 , 3–14.
Baron, J., Redick, J. A., Guengerich, F. P. (1981), An immunohistochemical study on the localization and
distributions of phenobarbital- and 3–methylcholanthrene-inducible cytochromes P-450 within the
livers of untreated rats,J. Biol. Chem. 256 , 5931–5937.
Becker, G. O., Berger, W., Domschke, G., Fangha ̈nsel, E., Faust, J., Fischer, M., Gentz, F., Gewald, K.,
Gluch, R., Mayer, R., Mu ̈ller, K., Pavel, D., Schmidt, H., Schollberg, K., Schwetlick, K., Seiler, E.,
Zeppenfeld, G. Ed. (1993), Organikum, Vol. 20, Leipzig: Barth Verlagsgesellschaft.
Benveniste, I., Tijet, N., Adas, F., Philipps, G., Salaun, J. P., Durst, F. (1998), CYP86A1 fromArabidopsis
thalianaencodes a cytochrome P450-dependent fatty acidx-hydroxylase,Biochem. Biophys. Res.
Commun. 243 , 688–693.
Berg, D., Plempel, M., Buchel, K. H., Holmwood, G., Stroech, K. (1988), Sterol biosynthesis inhibitors.
Secondary effects and enhanced in vivo efficacy,Ann. N. Y. Acad. Sci. 544 , 338–347.
Blanck, J., Janig, G. R., Schwarz, D., Ruckpaul, K. (1989), Role of lipid in the electron transfer between
NADPH-cytochrome P-450 reductase and cytochrome P-450 from mammalian liver cells,Xenobiotica
19 , 1231–1246.
Bocos, C., Gottlicher, M., Gearing, K., Banner, C., Enmark, E., Teboul, M., Crickmore, A., Gustafsson,
J. A. (1995), Fatty acid activation of peroxisome proliferator-activated receptor (PPAR),J. Steroid
Biochem. Mol. Biol. 53 , 467–473.
Boddupalli, S. S., Estabrook, R. W., Peterson, J.A. (1990), Fatty acid monooxygenation by cytochrome
P-450 BM-3,J. Biol. Chem. 265 , 4233–4239.
Boddupalli, S. S., Pramanik, B. C., Slaughter, C. A., Estabrook, R. W., Peterson, J. A. (1992), Fatty acid
monooxygenation by P450 BM-3: Product identification and proposed mechanism for the sequential
hydroxylation reactions,Arch. Biochem. Biophys. 292 , 20–28.
Bolwell, G. P., Bozak, K., Zimmerlin, A. (1994), Plant cytochrome P450,Phytochemistry 37 , 1491–1506.
Bornscheuer, U. T., Altenbuchner, J., Meyer, H. H. (1999), Directed evolution of an esterase: screening of
enzyme libraries based on pH-indicators and a growth assay,Bioorg. Med. Chem. 7 , 2169–2173.
Burke, D. F., Laughton, C. A., Neidle, S. (1997), Homology modelling of the enzyme P450 17a-hydro-
xylase/17,20 – lyase – a target for prostate cancer chemotherapy – from the crystal structure of
P450BM-3,Anticancer Drug Des. 12 , 113–123.
Cabello-Hurtado, F., Batard, Y., Salaun, J. P., Durst, F., Pinot, F., Werck-Reichhart, D. (1998), Cloning,
expression in yeast, and functional characterization of CYP81B1, a plant cytochrome P450 that cat-
alyzes in-chain hydroxylation of fatty acids,J. Biol. Chem. 273 , 7260–7267.
Capdevila, J. H., Wei, S., Helvig, C., Falck, J. R., Belosludtsev, Y., Truan, G., Graham-Lorence, S. E.,
Peterson, J. A. (1996), The highly stereoselective oxidation of polyunsaturated fatty acids by cyto-
chrome P450BM-3,J. Biol. Chem. 271 , 22663–22671.